Pfizer could be entering a tougher regulatory climate as CEO Albert Bourla warned that vaccine approvals in the U.S. have become more cha ...
The U.S. pharmaceutical industry needs to collaborate with China, given the country's relatively faster drug development, ...
Pfizer CEO Albert Bourla said people will "likely" need a booster dose of a COVID-19 vaccine within 12 months of getting fully vaccinated. His comments were made public Thursday but were taped April 1 ...
WASHINGTON -- Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals ...
Pfizer signed a deal with the White House to help Americans pay lower prices for prescription drugs. This agreement removes the uncertainty hanging over Pfizer's head related to the Trump ...
President Trump at 5p ET Friday will say that AstraZeneca has made a deal with the Trump administration to cut the prices of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback